Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1983 May 15;212(2):339–344. doi: 10.1042/bj2120339

Lipogenesis in liver, lung and adipose tissue of rats fed with oleoylanilide.

C Casals, P Garcia-Barreno, A M Municio
PMCID: PMC1152052  PMID: 6882376

Abstract

Oleoylanilide was administered orally to groups of rats according to different patterns. Subcellular fractionation of liver, lung and adipose tissue was then carried out in order to study the main enzyme activities involved in the lipogenesis. The observed findings indicate that adipose tissue and lung are the main target organs for the anilide, adipose tissue being involved in a general decrease of the enzyme activities, whereas transacylation reaction exhibits the most marked depletion of all the enzyme activities in the lung. The enzyme activities in liver were not markedly affected by this oral administration, although some data support the existence of a latent liver toxicity. These data suggest that oleoylanilide has the capacity to alter lipid metabolism of lung and adipose tissue to a considerable extent, whereas no major effect was produced in the liver. This different organ response could be related to the lymphatic gland via absorption of the substance.

Full text

PDF
339

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  2. Balibrea J. L., Garcia-Barreno B., Garcia-Barreno P., Municio A. M. Pulmonary lung and surfactant lipid biosynthesis in dogs under septic and hypovolemic shock syndromes. Int J Biochem. 1979;10(1):91–96. doi: 10.1016/0020-711x(79)90144-7. [DOI] [PubMed] [Google Scholar]
  3. Casals C., Acebal C., Cruz-Alvarez M., Estrada P., Arche R. Lysolecithin:lysolecithin acyltransferase from rabbit lung: enzymatic properties and kinetic study. Arch Biochem Biophys. 1982 Sep;217(2):422–433. doi: 10.1016/0003-9861(82)90520-3. [DOI] [PubMed] [Google Scholar]
  4. Fatty acid anilides and the toxic oil syndrome. Lancet. 1982 Jan 9;1(8263):98–99. [PubMed] [Google Scholar]
  5. Fatty acid anilides and the toxic oil syndrome. Lancet. 1982 Jan 9;1(8263):98–99. [PubMed] [Google Scholar]
  6. Fatty acid anilides and the toxic oil syndrome. Lancet. 1982 Jan 9;1(8263):98–99. [PubMed] [Google Scholar]
  7. Goerke J. Lung surfactant. Biochim Biophys Acta. 1974 Dec 16;344(3-4):241–261. doi: 10.1016/0304-4157(74)90009-4. [DOI] [PubMed] [Google Scholar]
  8. King R. J. The surfactant system of the lung. Fed Proc. 1974 Nov;33(11):2238–2247. [PubMed] [Google Scholar]
  9. Kyriakides E. C., Beeler D. A., Edmonds R. H., Balint J. A. Alterations in phosphatidylcholine species and their reversal in pulmonary surfactant during essential fatty-acid deficiency. Biochim Biophys Acta. 1976 Jun 22;431(3):399–407. doi: 10.1016/0005-2760(76)90206-x. [DOI] [PubMed] [Google Scholar]
  10. Martinez-Tello F. J., Navas-Palacios J. J., Ricoy J. R., Gil-Martín R., Conde-Zurita J. M., Colina-Ruiz Delgado F., Tellez I., Cabello A., Madero-García S. Pathology of a new toxic syndrome caused by ingestion of adulterated oil in Spain. Virchows Arch A Pathol Anat Histol. 1982;397(3):261–285. doi: 10.1007/BF00496569. [DOI] [PubMed] [Google Scholar]
  11. Moriya T., Kano H. In vivo studies on the de novo synthesis of molecular species of rat lung lecithins. Tohoku J Exp Med. 1974 Mar;112(3):241–256. doi: 10.1620/tjem.112.241. [DOI] [PubMed] [Google Scholar]
  12. Oldenborg V., van Golde L. M. Activity of cholinephosphotransferase, lysolecithin: lysolecithin acyltransferase and lysolecithin acyltransferase in the developing mouse lung. Biochim Biophys Acta. 1976 Sep 27;441(3):433–442. doi: 10.1016/0005-2760(76)90240-x. [DOI] [PubMed] [Google Scholar]
  13. Possmayer F., Duwe G., Hahn M., Buchnea D. Acyl specificity of CDPcholine: 1,2-diacylglycerol cholinephosphotransferase in rat lung. Can J Biochem. 1977 Jun;55(6):609–617. doi: 10.1139/o77-088. [DOI] [PubMed] [Google Scholar]
  14. Snyder C., Malone B., Nettesheim P., Snyder F. Urethan-induced pulmonary adenoma as a tool for the study of surfactant biosynthesis. Cancer Res. 1973 Oct;33(10):2437–2443. [PubMed] [Google Scholar]
  15. Starmer G. A., McLean S., Thomas J. Analgesic potency and acute toxicity of substituted anilides and benzamides. Toxicol Appl Pharmacol. 1971 May;19(1):20–28. doi: 10.1016/0041-008x(71)90185-2. [DOI] [PubMed] [Google Scholar]
  16. Toxic epidemic syndrome, Spain, 1981. Toxic Epidemic Syndrome Study Group. Lancet. 1982 Sep 25;2(8300):697–702. [PubMed] [Google Scholar]
  17. Vicario J. L., Serrano-Rios M., San Andrés F., Arnaiz-Villena A. HLA-DR3, DR4 increase in chronic stage of Spanish oil disease. Lancet. 1982 Jan 30;1(8266):276–276. doi: 10.1016/s0140-6736(82)90994-1. [DOI] [PubMed] [Google Scholar]
  18. Watkins J. C. The surface properties of pure phospholipids in relation to those of lung extracts. Biochim Biophys Acta. 1968 Mar 4;152(2):293–306. doi: 10.1016/0005-2760(68)90037-4. [DOI] [PubMed] [Google Scholar]
  19. Watkins W. D., Guess W. L. Toxicity of emetine to isolated embryonic chick-heart cells. J Pharm Sci. 1968 Nov;57(11):1968–1974. doi: 10.1002/jps.2600571130. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES